Don’t let the cost of darunavir disrupt your HIV treatment. Between generic darunavir at coupon prices near $61 a month, the J&J Patient Assistance Program, the $0 withMe card, and the Ryan White/ADAP safety net, an affordable route exists for nearly everyone. We find yours and manage it for a flat $69.95 per month.
The Prezista Patient Assistance Program is run by the Johnson & Johnson Patient Assistance Program (833-742-0791, Mon–Fri 8 AM–8 PM ET) and provides brand Prezista free of charge for up to a year to qualifying patients: household income up to 400% of the Federal Poverty Level, uninsured or insured with coverage gaps — including Medicare Part D enrollees (those at or below 150% FPL first document Extra Help ineligibility). But darunavir in 2026 is really a four-route drug, and the manufacturer program is rarely the cheapest door anymore: generic darunavir from ten-plus manufacturers fills at coupon prices near $61 a month; the withMe Savings Program takes commercially insured patients to $0 per fill; and every state’s ADAP covers darunavir for income-eligible residents, often with premium and copay help stacked on top. Sequencing those routes — and never letting a renewal or refill lapse, because consistent dosing is what maintains darunavir’s resistance barrier — is the actual work. For a flat $69.95 per month, our Patient Advocates run all four routes, confidentially, across every drug in the regimen.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$1,650.00 | Save ~$1,580/mo |
| CVS Pharmacy | ~$1,700.00 | Save ~$1,630/mo |
| Walmart | ~$1,500.00 | Save ~$1,430/mo |
| Costco | ~$1,450.00 | Save ~$1,380/mo |
Kroger | ~$1,470.00 | Save ~$1,400/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
Every route above is free to use directly. Our $69.95/month service covers full advocacy — sequencing generic, withMe, ADAP, and PAP correctly for your coverage, filing the documentation each demands, and keeping enrollment continuous across the full regimen, because darunavir never travels alone.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Prezista:
Still $1,400–$1,700 per month even with the best discount
The Johnson & Johnson Patient Assistance Program publishes clear eligibility rules for free Prezista. You will generally qualify if all of the following are true — and if your situation doesn’t fit neatly, contact AffordMyPrescriptions so we can review your case and determine if you qualify for Prezista assistance:
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Prezista (darunavir) is a second-generation HIV protease inhibitor — engineered to fit the protease enzyme so tightly that the virus struggles to mutate around it, giving darunavir one of the highest resistance barriers in HIV medicine.
How Prezista Works:
HIV’s protease enzyme performs the final cut-and-assemble step that turns immature viral particles into infectious virus. Darunavir binds that enzyme with exceptional affinity and flexibility, blocking assembly even against many protease mutations that defeat older drugs — the reason it anchors regimens for treatment-experienced patients and remains a guideline option for new starts. It’s always taken boosted (with ritonavir or cobicistat) and with food, which roughly doubles absorption.
Form and Use:
Once daily (800 mg with a booster) for most patients without darunavir resistance mutations; twice daily (600 mg boosted) for treatment-experienced patients with certain mutations. Tablets in multiple strengths plus an oral suspension for pediatric and swallowing-limited patients — the suspension has no generic, which makes it the genuine brand-assistance case. The booster makes darunavir an interaction hub: every new prescription from any provider needs checking against it.
Generic Availability:
Deep and real: generic darunavir tablets come from ten-plus manufacturers — Lupin first in mid-2023, with entrants as recent as 2025 — driving coupon prices to roughly $61–$70 per month, about 97% below brand. The tablets are substitutable at the counter; ask for generic pricing at every fill and compare it against your plan tier, because cash sometimes wins.
Warnings:
Darunavir contains a sulfonamide moiety — flag sulfa allergies. It can cause rash (rarely severe), liver enzyme elevations (monitored, especially with hepatitis co-infection), and the metabolic effects common to boosted protease inhibitors, including lipid changes. The boosting agent drives most drug interactions — statins, certain steroids and sedatives, ergot drugs, and more need adjustment or avoidance. Take with food, every time; unboosted or fasted dosing undercuts levels and invites resistance.
Brand runs about $2,116 per month — but generic darunavir, the same molecule, fills for as little as ~$61 with free discount coupons. Income-eligible patients can also receive brand free through the J&J Patient Assistance Program; our $69.95 monthly fee covers routing every fill to the cheapest correct path.
Yes — AB-rated, from ten-plus manufacturers, substitutable at the counter. The one exception is the oral suspension, which remains brand-only; pediatric and suspension patients route through the PAP or withMe instead.
Every state’s AIDS Drug Assistance Program covers HIV medications — darunavir included on formularies nationwide — for income-eligible residents, often with premium and copay help too. Income limits are more generous than most patients assume; we run the ADAP screening as step one of every enrollment.
Yes — antiretrovirals are a protected Part D class, so every plan must cover darunavir, with the $2,100 annual cap (2026) and monthly payment-plan smoothing. The withMe card can’t be used with Medicare, but Extra Help, ADAP, and the J&J PAP (within income limits) all can.
If you’re commercially insured, yes — $0 per fill, with a reported annual maximum around $7,500, excluding CA and MA residents. We verify the current terms at enrollment and switch you to the generic route if your plan’s math beats the card.
Food roughly doubles darunavir absorption, and the booster (ritonavir or cobicistat) blocks the enzyme that would clear it too fast — both are load-bearing parts of the regimen, not suggestions. Skipping either lowers drug levels and risks resistance, which closes doors permanently.
Denials are usually about documentation — income proof, the Extra Help letter, or incomplete prescriber sections. Applications can be corrected and resubmitted — and the ~$61 generic means nobody goes without medication while an appeal runs. We review the denial letter, fix what triggered it, and resubmit on your behalf.
A 97% generic discount, a $0 commercial card, a nationwide ADAP safety net, and a free-drug program at 400% of poverty — darunavir has more affordability routes than almost any HIV drug. The work is sequencing them and never letting a fill lapse; that work is ours. Check your eligibility today; the pre-qualification review is free, and if we can’t help you, you pay nothing.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.